2.37
price up icon4.87%   0.11
after-market After Hours: 2.32 -0.05 -2.11%
loading
Mangoceuticals Inc stock is traded at $2.37, with a volume of 60,483. It is up +4.87% in the last 24 hours and down -27.89% over the past month. Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.26
Open:
$2.25
24h Volume:
60,483
Relative Volume:
0.18
Market Cap:
$5.99M
Revenue:
-
Net Income/Loss:
$-7.32M
P/E Ratio:
-5.4147
EPS:
-0.4377
Net Cash Flow:
$-5.99M
1W Performance:
-0.84%
1M Performance:
-27.89%
6M Performance:
-40.15%
1Y Performance:
-73.22%
1-Day Range:
Value
$2.20
$2.37
1-Week Range:
Value
$2.10
$2.59
52-Week Range:
Value
$2.10
$16.80

Mangoceuticals Inc Stock (MGRX) Company Profile

Name
Name
Mangoceuticals Inc
Name
Phone
(833) 626-4679
Name
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MGRX's Discussions on Twitter

Mangoceuticals Inc Stock (MGRX) Latest News

pulisher
02:29 AM

Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World

02:29 AM
pulisher
Nov 03, 2024

Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 28, 2024
pulisher
Oct 26, 2024

Comparing Mangoceuticals (MGRX) and Its Peers - Defense World

Oct 26, 2024
pulisher
Oct 26, 2024

Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa

Oct 26, 2024
pulisher
Oct 26, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Reviewing Mangoceuticals (MGRX) & The Competition - Defense World

Oct 25, 2024
pulisher
Oct 24, 2024

Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World

Oct 24, 2024
pulisher
Oct 24, 2024

Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 24, 2024
pulisher
Oct 23, 2024

Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Mangoceuticals (MGRX) versus Its Rivals Head to Head Review - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire

Oct 22, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication By Investing.com - Investing.com UK

Oct 21, 2024
pulisher
Oct 21, 2024

Critical Contrast: Mangoceuticals (MGRX) and Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 21, 2024

Analyzing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Reviewing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and Its Competitors Head-To-Head Review - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and The Competition Critical Contrast - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Wetaskiwin Times Advertiser

Oct 18, 2024
pulisher
Oct 18, 2024

Mangoceuticals (MGRX) versus Its Competitors Financial Contrast - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Mangoceuticals, Inc. announced that it has received $0.15 million in funding - Marketscreener.com

Oct 17, 2024
pulisher
Oct 17, 2024

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga

Oct 17, 2024
pulisher
Oct 17, 2024

Contrasting Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Head-To-Head Comparison: Mangoceuticals (MGRX) & The Competition - Defense World

Oct 16, 2024
pulisher
Oct 15, 2024

Examining Mangoceuticals Inc (MGRX) more closely is necessary - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Mangoceuticals Inc (MGRX) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Upward Trajectory: Mangoceuticals Inc (MGRX) Posts a Slidee, Closing at 0.21 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Mangoceuticals Inc’s latest rating changes from various analysts - Knox Daily

Oct 14, 2024

Mangoceuticals Inc Stock (MGRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.22
price up icon 1.21%
health_information_services EVH
$23.36
price down icon 0.43%
$16.81
price down icon 2.55%
health_information_services WAY
$28.65
price down icon 0.42%
health_information_services RCM
$14.28
price up icon 0.14%
health_information_services HQY
$86.95
price up icon 0.72%
Cap:     |  Volume (24h):